Top 5 Medical Stocks To Buy For 2019

tags:ADM,SMPQY,BLPH,CDE,MSI,

Acceleron Pharma (NASDAQ: RGNX) and Regenxbio (NASDAQ:RGNX) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Valuation & Earnings

Get Acceleron Pharma alerts:

This table compares Acceleron Pharma and Regenxbio’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acceleron Pharma $13.48 million 165.15 -$108.45 million ($2.68) -18.06 Regenxbio $10.39 million 209.13 -$73.16 million ($2.45) -27.45

Regenxbio has lower revenue, but higher earnings than Acceleron Pharma. Regenxbio is trading at a lower price-to-earnings ratio than Acceleron Pharma, indicating that it is currently the more affordable of the two stocks.

Top 5 Medical Stocks To Buy For 2019: Archer-Daniels-Midland Company(ADM)

Advisors' Opinion:

• [By Lee Jackson]

  This is a very solid play for rocky markets and is offering a very reasonable entry point. Archer Daniels Midland Co. (NYSE: ADM) is a large agricultural services company with almost $90 billion in sales. It is in the business of converting agricultural harvest such as corn, wheat, soybeans and other products into basic ingredients for both consumer and industrial product manufacturers. Its main business lines are focused on oilseed processing, corn processing and agricultural services.

• [By Max Byerly]

  PNC Financial Services Group Inc. boosted its holdings in Archer Daniels Midland Co (NYSE:ADM) by 0.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 230,910 shares of the company’s stock after acquiring an additional 1,287 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Archer Daniels Midland were worth $10,581,000 at the end of the most recent quarter.

• [By Stephan Byrd]

  Lord Abbett & CO. LLC trimmed its position in Archer Daniels Midland Co (NYSE:ADM) by 14.3% during the 1st quarter, Holdings Channel reports. The firm owned 896,000 shares of the company’s stock after selling 149,800 shares during the period. Lord Abbett & CO. LLC’s holdings in Archer Daniels Midland were worth $38,860,000 at the end of the most recent quarter.

• [By Jon C. Ogg]

  Archer Daniels Midland Co. (NYSE: ADM) was raised to Buy from Hold at Stifel. ADM shares closed down 1.1% at $41.40 on Thursday and were indicated up 0.8% at $41.70 on Friday. The consensus target price is $53.40.

• [By Maxx Chatsko]

  China imported 55 million gallons of American ethanol from November 2017 to the end of February 2018. It could be just the beginning. That would be great news for Archer Daniels Midland (NYSE:ADM), Green Plains (NASDAQ:GPRE), and Valero Energy (NYSE:VLO) -- the three largest publicly traded ethanol producers in the United States.   

• [By Logan Wallace]

  LPL Financial LLC grew its holdings in shares of Archer Daniels Midland Co (NYSE:ADM) by 10.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,682 shares of the company’s stock after buying an additional 10,740 shares during the quarter. LPL Financial LLC’s holdings in Archer Daniels Midland were worth $4,757,000 at the end of the most recent reporting period.

Top 5 Medical Stocks To Buy For 2019: (SMPQY)

Advisors' Opinion:

• [By ]

  I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ:ENDP).

Top 5 Medical Stocks To Buy For 2019: Bellerophon Therapeutics, Inc.(BLPH)

Advisors' Opinion:

• [By Money Morning Staff Reports]

  However, it's unlikely Netlist repeats these returns anytime soon. After looking at last week's top performing penny stocks, we'll show you a penny stock on the verge of jumping over 230%…

  Penny Stock Current Share Price Last Week's Gain Netlist Inc. (Nasdaq: NLST) $0.83 542.67% Mannkind Corp. (Nasdaq: MNKD) $1.80 79.09% Fred's Inc. (Nasdaq: FRED) $2.49 73.68% Delcath Systems Inc. (OTCMKTS: DCTH) $3.70 72.63% Gemphire Therapeutics Inc. (Nasdaq: GEMP) $1.96 50.71% Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $1.05 47.98% Cel-Sci Corp. (NYSE: CVM) $3.78 44.78% ParkerVision Inc. (OTCMKTS: PRKR) $0.60 29.42% Superior Drilling Products Inc. (NYSE: SDPI) $2.63 29.23% LiqTech International Inc. (NYSE: LIQT) $1.50 25.20%

  How to Profit off This $11.1 Billion Money Pool: By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month thanks to a genius investment. Learn more…

• [By Shane Hupp]

  Radius Health (NASDAQ:RDUS) and Bellerophon Therapeutics (NASDAQ:BLPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

• [By Ethan Ryder]

  Bellerophon Therapeutics Inc (NASDAQ:BLPH)’s share price was up 0.8% during trading on Monday . The stock traded as high as $1.24 and last traded at $1.19. Approximately 1,061 shares were traded during trading, a decline of 100% from the average daily volume of 492,182 shares. The stock had previously closed at $1.20.

• [By Money Morning Staff Reports]

  After looking at last week's top performing penny stocks, we'll show you a penny stock that's on the verge of bringing you triple-digit returns…

  Penny Stock Current Share Price Last Week's Gain Orchids Paper Products Co. (NYSE: TIS) $2.60 218.83% China Rapid Finance Ltd. (NYSE: XRF) $2.69 69.01% Cel-Sci Corp. (NYSE: CVM) $1.21 42.17% Regulus Therapeutics Inc. (Nasdaq: RGLS) $0.29 33.40% Farmmi Inc. (Nasdaq: FAMI) $3.82 30.51% Biolase Inc. (Nasdaq: BIOL) $1.85 29.93% Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.18 26.99% Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $0.92 25.56% Inpixon (Nasdaq: INPX) $0.14 24.36% JMU Ltd. (Nasdaq: JMU) $1.58 24.05%

  While some of those returns look spectacular, we're not convinced these penny stocks will keep growing.

• [By Shane Hupp]

  Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares traded up 10% during mid-day trading on Monday after an insider bought additional shares in the company. The stock traded as high as $0.91 and last traded at $0.88. 18,690 shares were traded during mid-day trading, a decline of 95% from the average session volume of 388,757 shares. The stock had previously closed at $0.80.

• [By Shane Hupp]

  Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares saw strong trading volume on Friday after an insider bought additional shares in the company. 4,255,782 shares traded hands during trading, an increase of 888% from the previous session’s volume of 430,655 shares.The stock last traded at $1.00 and had previously closed at $0.83.

Top 5 Medical Stocks To Buy For 2019: Coeur d'Alene Mines Corporation(CDE)

Advisors' Opinion:

• [By Shane Hupp]

  Franco Nevada (NYSE: FNV) and Coeur Mining (NYSE:CDE) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Coeur Mining (CDE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Reuben Gregg Brewer]

  There's no way to sugarcoat it: 2017 was not a particularly good year for shareholders of silver and gold miner Coeur Mining, Inc. (NYSE:CDE). When it comes to investing, though, you need to balance the past with the future, and this miner's efforts in 2017 look like they will set up a much better long-term future. Here's why precious metals investors should be taking a closer look at Coeur Mining, but probably shouldn't rush to pull the trigger.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Coeur Mining (CDE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Coeur Mining Inc (NYSE:CDE) – Equities researchers at Cormark lifted their Q2 2018 earnings estimates for Coeur Mining in a note issued to investors on Tuesday, July 10th. Cormark analyst R. Gray now anticipates that the basic materials company will earn ($0.02) per share for the quarter, up from their previous estimate of ($0.05). Cormark also issued estimates for Coeur Mining’s Q3 2018 earnings at $0.02 EPS, Q4 2018 earnings at $0.07 EPS, FY2018 earnings at $0.07 EPS, Q1 2019 earnings at $0.15 EPS, Q2 2019 earnings at $0.15 EPS, Q3 2019 earnings at $0.15 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.60 EPS.

• [By Motley Fool Transcribers]

  Coeur Mining Inc  (NYSE:CDE)Q4 2018 Earnings Conference CallFeb. 21, 2019, 11:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Top 5 Medical Stocks To Buy For 2019: Motorola Solutions, Inc.(MSI)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Motorola Solutions (MSI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Morneau Shepell Inc (TSE:MSI) declared a monthly dividend on Tuesday, June 19th, Zacks reports. Investors of record on Friday, June 29th will be given a dividend of 0.065 per share on Monday, July 16th. This represents a $0.78 annualized dividend and a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 28th.

• [By Shane Hupp]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lowered its holdings in Motorola Solutions Inc (NYSE:MSI) by 4.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 434,200 shares of the communications equipment provider’s stock after selling 20,800 shares during the quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s holdings in Motorola Solutions were worth $45,721,000 as of its most recent SEC filing.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Motorola Solutions (MSI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Peter Graham]

  A long term performance chart shows Qualcomm breaking even while potential peers Cisco Systems, Inc (NASDAQ: CSCO) and Motorola Solutions Inc (NYSE: MSI) have performed better with their heir share of volatility:

• [By Logan Wallace]

  Norinchukin Bank The boosted its stake in shares of Motorola Solutions Inc (NYSE:MSI) by 16.8% during the first quarter, HoldingsChannel.com reports. The firm owned 15,755 shares of the communications equipment provider’s stock after purchasing an additional 2,263 shares during the quarter. Norinchukin Bank The’s holdings in Motorola Solutions were worth $1,659,000 as of its most recent filing with the Securities & Exchange Commission.